Nephrology Dialysis Transplantation
|
|
- Hortense Mathews
- 5 years ago
- Views:
Transcription
1 Nephrol Dial Transplant (1996) 11 [Suppl 2]: Nephrology Dialysis Transplantation Recirculation and the post-dialysis rebound J. E. Tattersall, P. Chamney, C. Aldridge and R. N. Greenwood Lister Hospital, Stevenage, UK Limitations to short haemodiaiysis It is now generally accepted that there is a significant risk of underdialysis if the treatment time is shortened towards 4 h or less. To avoid these risks, a return to longer dialysis times has been advocated, despite the increase in cost and inconvenience to the patient. An alternative strategy would be to understand the mechanism of reduced efficiency in short dialysis and specifically correct for it without resorting to long treatments. If it were possible to increase the rate of removal of fluid and solute mass in proportion to the reduction of dialysis time, without increasing the patient's fluid content, blood pressure or solute concentrations, then the short treatment would have equivalent efficacy to the long treatment. There are a number of factors which combine to reduce rate of fluid and solute removal in short dialysis. These include the relatively slow diffusion of middle and large molecular weight solutes, hypotension related to high ultrafiltration rates and the post-dialysis rebound. This paper will consider only the post-dialysis rebound, although it is accepted that other factors need to be considered when prescribing short dialysis. The rate at which solute can be removed from the patient is dependent on the dialyser clearance and on the rate at which solute can be conveyed from all parts of the body into the arterial needle. While the dialyser clearance rate is controllable and relatively easy to measure, the other factors are much more difficult to measure and are generally impossible to modify. For solute to travel from the intracellular compartment (which is the largest body water compartment) to the needle, it must cross the cell membrane, be carried into the central circulation by venous blood flow, be pumped into the aorta by the heart and carried to the needle by the fistula blood flow. Therefore the rate of transfer depends on the intra/extracellular mass transfer coefficient, regional bloodflowrates, cardiac output and fistula blood flow. The effect of these factors is to delay the rate at which solute is transferred into the fistula during Correspondence and offprint requests to: J. Tattersall, Renal Unit, Lister Hospital, Coreys Mill Lane, Stevenage SG1A KAB, UK. dialysis. The solute concentration in the fistula will, therefore, be lower than in the other compartments. This will reduce the rate at which solute is removed from the patient and results in an upward rebound in solute concentration after dialysis as the patient re-equilibrates. The multiple factors which delay solute transfer into the fistula from the patients are conveniently considered in different components, recirculation and inter-compartment transfer. Recirculation During haemodiaiysis, some of the blood entering the dialyser inlet has flowed from the dialyser outlet without passing through the peripheral capillaries. This flow of dialysed blood from dialyser outlet to inlet is termed recirculation and is quantified as the flow rate of recirculated blood entering the dialyser, expressed as a fraction of the extracorporeal blood flow rate. There are two types of recirculation, cardiopulmonary and access. Access recirculation 1996 European Dialysis and Transplant Association-European Renal Association Access recirculation does not normally occur during haemodiaiysis. It occurs when a proportion of the blood returning to the patient in the venous line is immediately drawn into the arterial needle and dialysed again without leaving the fistula (Figure 1). Access recirculation occurs only when the arterial needle is placed downstream of the venous needle or when the extracorporeal blood flow rate exceeds the blood flow rate in the fistula. In the case of incorrectly placed needles, the recirculated fraction will be the ratio of the extracorporeal blood flow rate to the fistula flow rate. Recirculation due to incorrectly placed needles commonly occurs in loop PTFE grafts where the direction of fistula flow is not obvious. Access recirculation due to limitations infistulaflow rate is relatively rare. Normally, fistula flow rates are well in excess of 700 ml/min and the extracorporeal blood flow rate is unlikely to exceed this. Recirculation of this kind is usually caused by a critical stenosis and is an indication that the fistula will soon clot. This kind of recirculation is critically dependent on the extfacorporeal blood flow rate; it is absent at low
2 76 7/ V Fig. 1. Access recirculation. The top panel shows the normal situation when there is no access recirculation. The middle panel shows recirculation due to the arterial needle (A) being incorrectly placed upstream of the venous needle (V). The lower panel shows access recirculation in a stenosed fistula with flow rates lower than the extracorporeal blood flow rate. extracorporeal blood flow rates but increases rapidly as the extracorporeal blood flow rate increases above the fistula flow rate. After dialysis ceases, the recirculated blood is rapidly washed out of the fistula and the solute concentration rebounds upwards. The rebound due to access recirculation is complete within a few seconds. Cardiopulmonary recirculation Cardiopulmonary recirculation is inevitable when dialysis is performed using a fistula as access [1]. In cardiopulmonary recirculation, blood recirculates from venous needle, fistula, venous circulation, right heart, lungs, left heart, aorta, fistula and into the arterial needle (Figure 2). The recirculated fraction will be the ratio of the extracorporeal blood flow rate to the cardiac output. Cardiopulmonary recirculation also causes a post-dialysis rebound which takes about 1 min as the recirculated blood clears the pulmonary circulation. The effect of recirculation on dialysis efficiency The rate at which solute mass is removed from the patient by the dialyser (in mmol/min) is the dialyser clearance rate (in 1/min) multiplied by the concentration of solute at the dialyser inlet (inmmol/1). Recirculation effectively reduces the solute concentration in the blood entering the dialyser by diluting it with cleared blood. Dialyser clearance is calculated J. E. Tattersall et al. from the ratio of concentrations entering and leaving the dialyser and is unaffected by their absolute values. Therefore, recirculation does not affect the dialyser clearance rate. However, by reducing the concentration in the dialyser inlet, recirculation does reduce the mass of solute removed. The dose of dialysis delivered is usually calculated from the ratio of pre- and post-dialysis blood solute concentrations. If the post-dialysis sample is taken before the rebound, the concentration will be reduced by recirculation and the calculated dose significantly overestimated. Since access recirculation may be significant, the post-dialysis sample must be taken after the access-related rebound is complete. The post-dialysis sample is usually taken from a sample port in the arterial line after the blood pump has been slowed to 50ml/min for 30 s. This time allows the recirculated blood to clear the fistula and for the fistula blood to be drawn up to the sample port. Cardiopulmonary recirculation has a small and predictable effect on dialysis efficiency and does not need to be measured routinely. However, access recirculation, if present, may have a major effect on efficiency and may indicate imminentfistulafailure. It is therefore important to detect access recirculation. If the routine measurement of dialysis dose delivered reveals an unexpected fall-off in efficiency or if there are any doubts about fistula performance, recirculation should be measured. Measurement of recirculation The three-sample method Until recently, this method was considered to be the 'gold standard' for measuring fistula recirculation [2]. This is calculated from the urea concentration in samples taken simultaneously from the dialyser inlet and outlet and from a peripheral vein. This method assumes that the peripheral sample is representative of arterial blood. Any difference between urea concentrations at the dialyser inlet and the peripheral vein is assumed to be due to recirculation from the dialyser outlet directly into the arterial needle, i.e. access recirculation. This has now been shown to be false. Although, in steady-state, the urea concentration does not differ significantly between sample sites, during dialysis there is a disequilibrium between sites. Cardiopulmonary recirculation causes the central venous blood to have a greater concentration than the arterial blood. Also, the peripheral vein has a greater concentration still [3,4]. Relatively slow blood flow in the skin and resting muscles drained by the peripheral veins results in their solute concentration falling more slowly than the central blood compartment (Figure 2). Recirculation measured by the three-sample method detects a combination of cardiopulmonary and access recirculation and also the disequilibrium between body vascular compartments. Most studies have shown recir-
3 Recirculation and the post-dialysis rebound artery Peripheral Circulation 400 ml/min peripheral vein 4 l/min central vein Fig. 2. Simple plan of the circulation. Cardiopulmonary recirculation occurs as some of the dialysed blood from the venous needle (V) flows through heart (RV, LV) and lungs back to the arterial needle (A) without passing through the capillary beds in the central and peripheral circulation. Intracellular solute must diffuse from the cells into the circulation (solid arrows) and is then carried by the blood flow into the fistula. This takes time and the delay reduces dialysis efficiency and causes the rebound. During dialysis, solute concentration will be higher in the peripheral veins than in the central veins and lowest in the arteries. This diagram shows only two of the many circulation compartments. culation fractions around 12% using the three-sample method [5]. method returns recirculation rates in the region of 5-15% due to this rebound artefact even when there is no fistula recirculation. The slowflowmethod This is a modification of the three-sample method. The peripheral sample is replaced by a sample from the dialyser inlet taken after the blood pump has been slowed to 50 ml/min for 30 s [6]. Under these conditions, the sample should reflect the arterial urea concentration and the method should detect only fistula recirculation. However, the timing of the slow flow sample is critical. If the sample is taken too soon, there will be insufficient time for dialysed blood to clear the fistula and for arterial blood to have been drawn up to the sample port. In this case the slow flow sample will be identical to the dialyser inlet sample and the recirculation fraction calculated will be zero whatever the true fraction may be. If, on the other hand, the slowflowsample is taken too late, the solute concentrations in thefistulawill have started to rebound upwards as dialysed blood clears the central circulation and solute re-equilibrates within the patient. Delays of more than 30 s in sampling at low flow will be affected unpredictably by this rebound and the calculated recirculation rates will be overestimates. In practice, this Saline dilution methods A bolus of saline is injected into the venous line during dialysis and is detected in the arterial line a short time later [7]. By comparing the size of the saline bolus detected in the arterial line with its original size as it enters the fistula, the recirculated fraction may be calculated. If there is access recirculation, a saline bolus will be detected in the arterial line within seconds of its passage into the fistula. The cardiopulmonary recirculation will result in a saline bolus being detected approximately 1 min after its passage into the fistula, as the saline will have passed around the pulmonary circulation. Therefore, this method may distinguish between fistula and cardiopulmonary recirculation and calculate their fractions separately. The blood temperature module This method uses the same principle as the saline dilution method, but a thermal bolus replaces the saline [8]. A bolus of blood at about 35 C is produced
4 78 by reducing the temperature of the dialysate for about 2 min. This cool blood is detected and quantified by a temperature sensor on the venous line. Recirculation of the cool blood bolus into the arterial line is detected by another sensor. Since the duration of the cool bolus is about 2 min, this method cannot distinguish between fistula and cardiopulmonary recirculation and its precision is relatively low at approximately 50-10%. However, this method is much less invasive than the other methods as no injections or samples are required. Also, this method is the simplest to operate as the module is part of the dialysis machine, the temperature sensors operate from outside unmodified blood lines and the entire system is under automatic control. The operator simply presses a button and the module displays the recirculated fraction approximately 2 min later. The occlusion method The fistula is occluded between the arterial and venous needles by finger pressure. If there is access recirculation, the pressure in the arterial line will fall rapidly and the dialysis machine will alarm. This is because part of the flow into the arterial line was recirculated blood from the venous line and was stopped by the finger pressure. This method does not detect cardiopulmonary recirculation and is very easy to perform. However, if the fistula needles are very close together or the fistula is a deep prosthetic graft, it may be difficult or impossible to occlude by finger pressure. Interpreting the recirculated fraction Since access recirculation is critically dependent on the extracorporeal blood flow rate, recirculation should always be measured at the highest extracorporeal blood flow rate likely to be used during dialysis. Methods which detect a combination of cardiopulmonary and access recirculation (blood temperature module, slow flow method) will generally return a value of up to 15% due to cardiopulmonary recirculation. If the recirculation fraction is much greater than 15% then access recirculation is likely. If access recirculation is detected and needle position errors have been excluded, then it is helpful to determine thefistulaflow rate. This is achieved by measuring recirculation at different blood flows and determining the maximum blood flow at which no access recirculation occurs. If the method detects both cardiopulmonary and access recirculation, than the fistula flow rate may be determined by analysing the relationship between blood flow and recirculation (Figure 3). Dialysis should not be performed using blood flow rates in excess of the fistula flow rate and the dialysis time should be increased to compensate for the reduction in blood flow rate. Since access recirculation is usually due to critical stenosis and may precede complete failure, further investigation of the fistula is needed. RF(%) Qb (ml/min) J. E. Tattersall et al Fig. 3. The relationship between the recirculated fraction (RF) and extracorporeal blood flow rate (Qb). The data points represent measurements in a patient. In this case, the fistula flow rate was limited to 370 ml/min by stenosis. So long as the extracorporeal blood flow rate is less than the fistula flow rate (Qf) then the recirculated fraction is Qb/CO, where CO is the cardiac output. When Qb>Qf, the recirculated fraction is 1 -Qf(CO-Qf )/CO/Qb. Intercompartment solute transfer The major component of the post-dialysis rebound is due to solute transfer between compartments [9]. The body can be considered to be made up of multiple aqueous compartments which contain solute. These compartments include the cells, gut, regions of the body where there is relatively low blood flow, the main blood circulation and the fistula. The dialyser clears only the fistula directly. Solute in all other compartments will transfer into the fistula at finite and variable rates. The mechanism of solute transfer between compartments may be diffusion, for example across cell membranes, or it may be flow, for example from poorly perfused areas into the main circulation. The solute concentration in the fistula depends not only on the dialyser clearance but also on the rate at which solute is transferred into the fistula from other compartments. The slower the intercompartment transfer relative to the dialyser clearance the lower the solute concentration in the fistula. Intercompartment solute transfer has the same effect on dialysis efficiency as does recirculation. It reduces the solute concentration in the fistula and, therefore, dialyser inlet which has the effect of reducing the rate at which solute is removed from the patient without affecting the dialyser clearance. After dialysis the solute concentration rebounds upwards as the patient re-equilibrates, taking about 30 min to complete. Taking the rebound into consideration in planning dialysis Both cardiopulmonary recirculation and intercompartment transfer become more important as the dialyser
5 Recirculation and the post-dialysis rebound clearance rate increases. In short, high clearance dialysis, the solute concentrations at the dialyser inlet are lower throughout dialysis than in a longer, slower dialysis. This is due to the greater degree of recirculation and intercompartment disequilibrium and results in a lower mass of solute removed despite similar clearances and Kt/V. These effects also result in the post-dialysis rebound which is, again, relatively greater after short, rapid dialyses (Figure 4). If dialysis is quantified using pre- and immediate post-dialysis blood solute concentrations, the dose of dialysis will be overestimated, particularly in short, rapid dialysis. In prescribing dialyses, it is necessary to add extra dialysis dose to compensate for the recirculation and intercompartment transfer effects. This extra dose will be relatively greater in rapid dialyses. In the measurement of dialysis dose actually delivered, the mass of solute actually removed during dialysis must be measured in a total or partial dialysate collection. Alternatively, if the dialysis is quantified using pre- and post-dialysis blood solute concentrations, the post-dialysis sample must be drawn after the rebound is complete at least 30 min post-dialysis. The patient clearance time Dialysis efficiency can be considered to be limited by the rate at which urea can be delivered from the different compartments of the body into the fistula. This rate depends on cardiac output, blood flow in the different regions of the body, and the rate of diffusion across cell membranes. The mathematics describing these effects are similar and surprisingly simple [10], reducing to a single time constant the patient clearance time. This is the time needed to clear the peripheral compartments of the body and is, in effect, the urea concentration (mm) ! 22 P IIffiffr^ I time (min) Fig. 4. Plot of urea concentration against time. The data points represent the mean of 29 measurements in 29 different patients treated by long and short dialysis on consecutive weeks. The lines represent concentrations predicted by single (dotted) and double pool (solid lines) UKMs with Kt/V=\. The addition of 30min to the dialysis time (shaded area) corrects for the effect of the rebound in both long and short dialyses. mean of the ratios of intercompartment mass transfer rate (flow rate or diffusion coefficient) to the volumes of the peripheral compartments. The patient clearance time is approximately 30 min and comprises F/cardiac output (approximately 6 min) for cardiopulmonary recirculation and 24 min for intercompartment transfer. The patient clearance time (tp) may be calculated from the observed post-dialysis solute rebound in individual patients from the equation tp = td{ktvi/ktvr-l) where Ktvi and Ktvr are the Kt/V calculated by singlepool UKM using immediate and 1 h post-dialysis urea concentrations. This time is independent of the dialyser clearance and is reproducible. The patient clearance time is also relatively constant between patients. Assuming a clearance time of 30 min for all patients may be an acceptable approximation and avoids the need to measure it individually. The patient clearance time can be used to correct for the effects of the rebound on dialysis efficiency. In the prescription of dialysis time, the patient clearance time should be added for each unit of Kt/V prescribed. Whereas dialysis time is normally prescribed using the formula t = [desired Kt/V]V/K the 30 min patient constant should be included thus: = [desired Kt/V](V/K + 30) This will have the effect of increasing a 4 h dialysis by 12% and a 2 h dialysis by 25% (Figure 4). In the measurement of dialysis dose delivered, the 30 min constant can be used to correct the Kt/V calculated conventionally from pre- and immediate post-dialysis solute concentrations by multiplying it by td/(td+30). This will effectively reduce the Kt/V calculated by 10-25% depending on the dialysis time. Conclusion The mass of solute removed by dialysis is reduced by recirculation and intercompartment transfer effects. These effects are relatively greater in short, rapid dialyses and must be taken into account. Access recirculation should be avoided altogether. The quantification of dialysis using pre- and post dialysis urea will effectively take access recirculation into account if the post-dialysis sample is taken at least 30 s after dialysis has effectively stopped. This allows recirculated blood to clear the fistula and arterial blood to be drawn up to the sample port. If access recirculation is suspected then it should be measured at different blood flow rates to determine the maximum blood flow rate possible without access recirculation. The effects of cardiopulmonary recirculation and intercompartment transfer on dialysis quantification may be taken into account by using the dialysate collection method or the pre- and post-dialysis blood 79
6 80 sample method, provided the post-dialysis sample is taken at least 30min after the dialysis has ended to allow the rebound to complete. Alternatively, pre- and immediate post-dialysis samples may be used but the resulting Kt/V corrected by multiplying by td/(td+30). When prescribing dialysis, an extra 30 min per unit of Kt/V prescribed should be added to allow for intercompartment transfer and cardiopulmonary recirculation. References 1. Schneditz D, Polaschegg HD, Levin NW, Cu GA, Morris AT, Kramer M, Daugirdas JT, Kaufman AM. Cardio-pulmonary recirculation in dialysis. An underrecognized phenomenon. ASAIO J 1992; 38: M Gibson SM, Von Albertini B, Bosch JP. Reproducible measurement of recirculation without peripheral venipuncture. Kidney Int 1990; 37: 297 (abstract) J. E. Tattersall et al. 3. Sherman RA. Recirculation revisited. Semin Dial 1991; 4: Buur T, Will EJ. Haemodialysis recirculation using a femoral artery sample. Nephrol Dial Transplant 1994; 9: Tattersall JE, Farrington K, Raniga PD, Thompson H, Tomlinson C, Aldridge C, Greenwood RN. Haemodialysis recirculation detected by the three-sample method is an artefact. Nephrol Dial Transplant 1993; 8: Sherman RA, Levy SS. Assessment of a two-needle technique for the measurement of recirculation during hemodialysis. Am J Kidney Dis 1991; 18: Aldridge C, Greenwood RN, Frampton CF, Wilkinson JS, Cattell WR. Instrument design for the bedside assessment of arteriovenous fistulae in haemodialysis patients. Proc EDTNA- ERCA 1985; 14: Kramer M, Polaschegg HD. Automated measurement of recirculation. EDTNA-ERCA J 1993; 19: Pendrini PR, Zereik S, Rasmy S. Causes, kinetics and clinical implications of post-hemodialysis urea rebound. Kidney Int 1988; 34: Tattersall JE, Greenwood RN, Farrington K. Intercompartment diffusion and cardio-pulmonary recirculation in long and short dialyses. J Am Soc Nephrol 1994; 5: 530
Hemodialysis today has evolved
Lessons in Dialysis, Dialyzers, and Dialysate Robert Hootkins, MD, PhD The author is Chief of Nephrology and Hypertension at The Austin Diagnostic Clinic, Austin, Texas. He is also a member of D&T s editorial
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Blood urea sampling methods GUIDELINES
Date written: November 2004 Final submission: July 2005 Blood urea sampling methods GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions are
More informationNephrology Dialysis Transplantation
Nephrol Dial Transplant (1996) 11 [Suppl 8]: 10-15 Nephrology Dialysis Transplantation Urea, sodium, and water changes in profiling dialysis H. Mann and S. Stiller ntroduction Control of osmolarity, as
More informationConfidence limits of arteriovenous fistula flow rate measured by the on-line thermodilution technique
Nephrol Dial Transplant (2003) 18: 955 960 DOI: 10.1093/ndt/gfg075 Original Article Confidence limits of arteriovenous fistula flow rate measured by the on-line thermodilution technique Joe L. Ragg, John
More informationThe measurement of blood access flow rate (Qa; ml/min)
Hemodialysis Blood Access Flow Rates Can Be Estimated Accurately from On-Line Dialysate Urea Measurements and the Knowledge of Effective Dialyzer Urea Clearance Robert M. Lindsay,* Jan Sternby, Bo Olde,
More informationThere are no shortcuts to Dialysis
There are no shortcuts to Dialysis 1 Outcomes John Sweeny Wednesday, March 21 st, 2018 (3:10 pm 4:10 pm) 2 Quality in Hemodialysis Quality Health Care is the degree to which health services increases the
More informationCSI (Clinical Scenario Investigation): Hyperkalemia
CSI (Clinical Scenario Investigation): Hyperkalemia Alison Thomas, RN(EC), MN, CNeph(C) Ann Jones, RN(EC), MSN, CNeph(C) Joyce Hunter, RN, Vascular Access Co-ordinator Simcoe Muskoka Regional Kidney Care
More informationPhil. J. Internal Medicine, 47: 19-23, Jan.-Feb., 2009
Original Articles Assessment of Hemodialysis Adequacy 19 Phil. J. Internal Medicine, 47: 19-23, Jan.-Feb., 2009 ASSESSMENT OF HEMODIALYSIS ADEQUACY: IONIC DIALYSANCE IN COMPARISON TO STANDARD METHOD KT/V-MAKATI
More informationExplorations fonctionnelles des abords vasculaires pour hémodialyse
Explorations fonctionnelles des abords vasculaires pour hémodialyse Frank Le Roy Nephrology Department Actualités Néphrologiques Jean Hamburger Necker, 27 avril 2015 1966 Brescia, Cimino, Appel, Hurwich.
More informationVasopressin secretion by hypertonic saline infusion during hemodialysis: effect of cardiopulmonary recirculation
Nephrol Dial Transplant (2011) 0: 1 8 doi: 10.1093/ndt/gfr272 NDT Advance Access published June 1, 2011 Original Article Vasopressin secretion by hypertonic saline infusion during hemodialysis: effect
More informationHaemodialysis. Online Clearance Monitoring Assuring the Desired Dose of Dialysis
Haemodialysis Online Clearance Monitoring Assuring the Desired Dose of Dialysis Contents 1. Foreword 2. Dialysis dose 2.1 Standard methods of determination of the dialysis dose 2.1.1 Urea Reduction Ratio
More informationKaren Mak R.N. (Team Leader) Renal Dialysis Centre Hong Kong Sanatorium & Hospital
Karen Mak R.N. (Team Leader) Renal Dialysis Centre Hong Kong Sanatorium & Hospital - Renal Transplantation - Peritoneal Dialysis - Extracorporeal Therapy Extracorporeal Therapy It is the procedure in
More informationIN THE NAME OF GOD Uremic toxins I. Small (< 500 D); water soluble Surrogate marker urea or sodium (ionic dialysance) Rapidly produced in intracellular fluid compartment Large variability in intra-patient
More informationIN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006
IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006 PATIENT IDENTIFICATION [Before completing please read instructions at the bottom of this page and on pages 5 and 6] MAKE
More informationNephrology Dialysis Transplantation
Nephrol Dial Transplant (1998) 13: 3138 3146 Original Article Nephrology Dialysis Transplantation Urea kinetic modelling are any of the bedside Kt/V formulae reliable enough? Adrian Covic1, David J. A.
More informationSupplemental Quick Reference Guide
Supplemental Quick Reference Guide How to use this Supplemental Quick Reference Guide This guide provides a 5-step method for considering a variety of frequencies and treatment lengths, based on achieving
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES
Date written: August 2004 Final submission: July 2005 Monitoring patients on peritoneal dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationNursing Care of the Dialysis Patient. Adrian Hordon, MSN, RN
Nursing Care of the Dialysis Patient Adrian Hordon, MSN, RN Understand principles of hemodialysis Recognize different access ports Identify side effects and complications Discuss nursing care for pre and
More informationAna Paula Bernardo. CHP Hospital de Santo António ICBAS/ Universidade do Porto
Ana Paula Bernardo CHP Hospital de Santo António ICBAS/ Universidade do Porto Clinical relevance of hyperphosphatemia Phosphate handling in dialysis patients Phosphate kinetics in PD peritoneal phosphate
More informationAssessing adequacy of hemodialysis: Urea modeling
Kidney International, Vol. 45 (1994), pp. 1522 1535 NEPHROLOGY FORUM Assessing adequacy of hemodialysis: Urea modeling Principal discussant: THOMAS A. DEPNER University of California Davis Medical Center,
More informationHaemodialysis with on-line monitoring equipment: tools or toys?
Nephrol Dial Transplant (2005) 20: 22 33 doi:10.1093/ndt/gfh555 Special Feature Haemodialysis with on-line monitoring equipment: tools or toys? Francesco Locatelli 1, Umberto Buoncristiani 2, Bernard Canaud
More informationCRRT for the Experience User 1. Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference March, 2018
CRRT for the Experience User 1 Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference March, 2018 Disclosures I have no actual or potential conflict of interest
More informationSt George Hospital Renal Department Guideline: INTERNAL ONLY ANTICOAGULATION - COMMENCEMENT OF HAEMODIALYSIS
ANTICOAGULATION - COMMENCEMENT OF HAEMODIALYSIS Summary Aim: To prevent clotting of the extracorporeal circuit during haemodialysis If there are no contraindications, heparin can be used. In the first
More informationRisk factors for increased variability in dialysis delivery in haemodialysis patients
Nephrol Dial Transplant (2003) 18: 2112 2117 DOI: 10.1093/ndt/gfg297 Original Article Risk factors for increased variability in dialysis delivery in haemodialysis patients K. Scott Brimble, Darin J. Treleaven,
More information[1] Levy [3] (odds ratio) 5.5. mannitol. (renal dose) dopamine 1 µg/kg/min atrial natriuretic peptide (ANP)
[1] Levy [3] 183 174 (odds ratio) 5.5 Woodrow [1] 1956 1989 mannitol (renal dose) dopamine 1 µg/kg/min atrial natriuretic peptide (ANP) McCarthy [2] 1970 1990 insulin-like growth factor-1 (IGF-1) ANP 92
More informationCardiac output and urea kinetics in dialysis patients: Evidence supporting the regional blood flow model
Kidney International, Vol. 5 (1996), pp. 1273-2277 Cardiac output and urea kinetics in dialysis patients: Evidence supporting the regional blood flow model TITILA. GEORGE, ADRIAN PRIESTER-COARY, GEORGE
More informationUNDERSTANDING THE CRRT MACHINE
UNDERSTANDING THE CRRT MACHINE Helen Dickie Renal Sister Critical Care Unit Guy s and St.Thomas NHS Foundation Trust 18.10.14 RRT options - IHD vs CRRT (1) Intermittent HaemoDialysis e.g. 4hrs daily or
More informationSolute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters
Nephrol Dial Transplant (2003) 18: 961 966 DOI: 10.1093/ndt/gfg055 Original Article Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100
More informationmean hemoglobin 11 g/dl (110 g/l) compared to patients with lower mean hemoglobin values (Table 20).
S44 Figure 53 depicts the trend in Epoetin dosing from the 1998 study period to the 2003 study period, with an increasing mean weekly Epoetin dose (units/kg/wk) for patients prescribed Epoetin in lower
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES
Date written: September 2004 Final submission: February 2005 Mode of dialysis at initiation GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationGUIDELINE FOR HAEMODIALYSIS PRESCRIPTION FOR NEW PATIENTS COMMENCING HAEMODIALYSIS
GUIDELINE FOR HAEMODIALYSIS PRESCRIPTION FOR NEW PATIENTS COMMENCING HAEMODIALYSIS RRCV CMG Nephrology Service 1. Introduction A first acute or chronic haemodialysis session may induce disequilibrium syndrome
More informationOnline HD monitoring (BVM, OCM, BTM, etc.): Useful tools or fancy toys?
Online HD monitoring (BVM, OCM, BTM, etc.): Useful tools or fancy toys? Patrice Ambühl Basics in SSN/SGN Meeting, December 4 2013 patrice.ambuehl@waid.zuerich.ch Nephrologie Therapeutical dilemma Ultrafiltra
More informationAdvances in Peritoneal Dialysis, Vol. 23, 2007
Advances in Peritoneal Dialysis, Vol. 23, 2007 Antonios H. Tzamaloukas, 1,2 Aideloje Onime, 1,2 Dominic S.C. Raj, 2 Glen H. Murata, 1 Dorothy J. VanderJagt, 3 Karen S. Servilla 1,2 Computation of the Dose
More informationObjectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring
Peritoneal Dialysis Prescription and Adequacy Monitoring Christine B. Sethna, MD, EdM Division Director, Pediatric Nephrology Cohen Children s Medical Center Associate Professor Hofstra Northwell School
More informationControl of hyperphosphatemia is a major goal in patients
ORIGINAL ARTICLES Phosphorus Clearance Using Two Hemodialyzers Placed in Parallel Mitchell H. Rosner, 1,2 Allen Helmandollar, 1 Ryan Evans, 1 Emaad Abdel-Rahman 1 Division of Nephrology, 1 University of
More informationIN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2001
IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2001 [Before completing please read instructions at the bottom of this page and on pages 4 and 5] PATIENT IDENTIFICATION MAKE
More informationReal-time Kt/V determination by ultraviolet absorbance in spent dialysate: technique validation
http://www.kidney-international.org & 21 International Society of Nephrology see commentary on page 833 Real-time Kt/V determination by ultraviolet absorbance in spent dialysate: technique validation Alex
More informationKidney Failure. Haemodialysis
Kidneys & Kidney Failure 2 Haemodialysis This booklet will help you to know the process of Haemodialysis in detail. It will also tell you about the disposables of Haemodialysis. In the end the advantages
More information2019 Home Hemodialysis Standing Orders
2019 Home Hemodialysis Standing Orders 1. Nutrition Standards of Care: A. Follow P&P Nutrition Standards of Care 2. Laboratory Tests: A. Drawn On Admission: 1. Renal Function Panel (BMP, PO 4 and Albumin)
More informationA New Technique for Repeated Measurement of Cardiac Output During Cardiopulmonary Resuscitation
Purdue University Purdue e-pubs Weldon School of Biomedical Engineering Faculty Publications Weldon School of Biomedical Engineering 1980 A New Technique for Repeated Measurement of Cardiac Output During
More informationNDT Advance Access published April 12, 2006
NDT Advance Access published April, 6 Nephrol Dial Transplant (6) of 7 doi:.93/ndt/gfl47 Original Article Dialysis dose (Kt/V) and clearance variation sensitivity using measurement of ultraviolet-absorbance
More informationLeft ventricular hypertrophy: why does it happen?
Nephrol Dial Transplant (2003) 18 [Suppl 8]: viii2 viii6 DOI: 10.1093/ndt/gfg1083 Left ventricular hypertrophy: why does it happen? Gerard M. London Department of Nephrology and Dialysis, Manhes Hospital,
More informationHEMODIALFILTRATION LITERATURE REVIEW AND PRACTICE CONSIDERATIONS 1.0 PRACTICE CONSIDERATIONS 2.0 CURRENT LITERATURE REVIEW
HEMODIALFILTRATION LITERATURE REVIEW AND PRACTICE CONSIDERATIONS This document was prepared at the request of the BC Hemodialysis Committee to provide a brief overview of the literature and to identify
More informationHaemodialysis Machines H/S Visually the best dialysis results
Haemodialysis Machines 4008 H/S Visually the best dialysis results Therapy Through continuous optimisation of the treatment modalities Fresenius Medical Care always aims to offer patients the best renal
More informationHaemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health
Haemodiafiltration - the case against Prof Peter G Kerr Professor/Director of Nephrology Monash Health Know your opposition.. Haemodiafiltration NB: pre or post-dilution What is HDF how is it different
More informationDialysis Adequacy (HD) Guidelines
Dialysis Adequacy (HD) Guidelines Peter Kerr, Convenor (Monash, Victoria) Vlado Perkovic (Camperdown, New South Wales) Jim Petrie (Woolloongabba, Queensland) John Agar (Geelong, Victoria) Alex Disney (Woodville,
More informationNew method of blood purification (Recycle Filtration System)
Tokai J Exp Clin Med., Vol. 33, No. 3, pp. 124-129, 2008 New method of blood purification (Recycle Filtration System) Hajime SUZUKI 1), Miho HIDA 1), Makoto KITAMURA 1), Shin-ichi TANAKA 2), Takayo MIYAKOGAWA
More informationTREATMENT SAFETY AND EFFECTIVENESS CONTROL OF MODERN DIALYSIS MACHINES
TREATMENT SAFETY AND EFFECTIVENESS CONTROL OF MODERN DIALYSIS MACHINES Sarajevo, October 5 th, 2017 Modern dialysis machines have evolved from the early cumbersome and inefficient devices to those with
More informationCan We Achieve Precision Solute Control with CRRT?
Can We Achieve Precision Solute Control with CRRT? Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference February, 2019 Disclosures I have no actual or potential
More informationANTIBIOTIC DOSE AND DOSE INTERVALS IN RRT and ECMO
ANTIBIOTIC DOSE AND DOSE INTERVALS IN RRT and ECMO Professor Jeffrey Lipman Department of Intensive Care Medicine Royal Brisbane Hospital University of Queensland NO CONFLICT OF INTERESTS Important concept
More informationPrevalence of Access Recirculation in Prevalent Arterio-Venous (A-V) Fistula Hemodialysis Patients and Its Effect on Hemodialysis Adequacy
The Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (6), Page 4602-4609 Prevalence of Access Recirculation in Prevalent Arterio-Venous (A-V) Fistula Hemodialysis Patients and Its Effect on Hemodialysis
More informationContinuous Renal Replacement Therapy. Gregory M. Susla, Pharm.D., F.C.C.M. Associate Director, Medical Information MedImmune, LLC Gaithersburg, MD
Continuous Renal Replacement Therapy Gregory M. Susla, Pharm.D., F.C.C.M. Associate Director, Medical Information MedImmune, LLC Gaithersburg, MD 1 Definition of Terms SCUF - Slow Continuous Ultrafiltration
More information- SLED Sustained Low-Efficiency Dialysis
Continuous Renal Replacement Therapy Gregory M. Susla, Pharm.D., F.C.C.M. Associate Director, Medical Information MedImmune, LLC Gaithersburg, MD 1 Definition of Terms - SCUF - Slow Continuous Ultrafiltration
More informationA device and a method for rapid and accurate measurement of
Kidney International, VoL 49 (1996), pp. 1152 116 TEHNIAL NOTE A device and a method for rapid and accurate measurement of access recirculation during hemodialysis ROBERT M. LINDSAY, JEFF BURBANK, JAMES
More informationASN DIALYSIS ADVISORY GROUP ASN DIALYSIS CURRICULUM
ASN DIALYSIS ADVISORY GROUP ASN DIALYSIS CURRICULUM Medical Management of Home Hemodialysis Patients Brent W. Miller, MD Professor of Medicine Washington University School of Medicine Saint Louis, Missouri
More informationContinuous Renal Replacement Therapy
Continuous Renal Replacement Therapy Gregory M. Susla, Pharm.D., F.C.C.M. Associate Director, Medical Information MedImmune, LLC Gaithersburg, MD Definition of Terms SCUF - Slow Continuous Ultrafiltration
More informationStaff-Assisted Home Hemodialysis
Medical Coverage Policy Staff-Assisted Home Hemodialysis Table of Contents Coverage Policy... 1 Overview... 1 General Background... 2 Coding/Billing Information... 4 References... 4 Effective Date...11/15/2017
More informationBPG 03: Continuous Renal Replacement Therapy (CRRT)
BPG 03: Continuous Renal Replacement Therapy (CRRT) Statement of Best Practice Patient s requiring Continuous Renal Replacement Therapy (CRRT) will receive appropriate therapy to meet their individual
More informationDialysis System DBB-07
Dialysis System DBB-07 The flexible solution Innovations for Human Care. 0123 Times are changing, we have the solution. DBB-07 Dialysis System The challenge The demand of dialysis treatment methods should
More informationAdequacy of haemodialysis and nutrition in maintenance haemodialysis patients: clinical evaluation of a new on-line urea monitor
Nephrol Dial Transplant (1996) 11: 1568-1573 Original Article IMephrology Dialysis Transplantation Adequacy of haemodialysis and nutrition in maintenance haemodialysis patients: clinical evaluation of
More informationThe kidneys maintain the body s homeostasis by
Rationale for Daily Dialysis Umberto Buoncristiani, Riccardo Fagugli, Giuseppe Quintaliani, Hrissanti Kulurianu Nephrology-Dialysis Unit, Ospedale Regionale, Perugia, Italy. The kidneys maintain the body
More informationEvaluation of AVF and AVG
Evaluation of AVF and AVG 2013 Nephrology Nursing Symposium Albuquerque Vascular Access Leading cause of hospitalization in the ESRD population Annual cost approaching $1.5 billion (USRDS, 2004) Current
More informationHaemodialysis. 4008S Visually the best dialysis results
Haemodialysis 4008S Visually the best dialysis results Therapy Through continuous optimisation of the treatment modalities Fresenius Medical Care always aims to offer patients the best renal replacement
More informationImplementing therapy-delivery, dose adjustments and fluid balance. Eileen Lischer MA, BSN, RN, CNN University of California San Diego March 6, 2018
Implementing therapy-delivery, dose adjustments and fluid balance. Eileen Lischer MA, BSN, RN, CNN University of California San Diego March 6, 2018 Objectives By the end of this session the learner will
More informationHD Scanning: Velocities and Volume Flow
HD Scanning: Velocities and Volume Flow Non-Invasive Lab Symposium West Orange, NJ April 27, 2018 Volume Flow Cindy Sturt, MD, FACS, RVT 500,000 Americans on dialysis 20-25% annual mortality 65% 5 year
More informationThe peritoneal equilibration test (PET) was developed THE SHORT PET IN PEDIATRICS. Bradley A. Warady and Janelle Jennings
Peritoneal Dialysis International, Vol. 27, pp. 441 445 Printed in Canada. All rights reserved. 0896-8608/07 $3.00 +.00 Copyright 2007 International Society for Peritoneal Dialysis THE SHORT PET IN PEDIATRICS
More informationHaemodialysis. The AutoFlow Function for the 5008 Therapy System Optimising the Dialysis Fluid Flow Rate
Haemodialysis The AutoFlow Function for the 5008 Therapy System Optimising the Dialysis Fluid Flow Rate 2 The Dialysis Fluid Flow Rate In current dialysis practice, a dialysis fluid flow rate of either
More informationMANITOBA RENAL PROGRAM
SUBJECT Venipuncture of Arteriovenous Fistula/Graft MANITOBA RENAL PROGRAM SECTION CODE 30.30.01 30.30 Vascular Access AUTHORIZATION Professional Advisory Committee, Manitoba Renal Program Nursing Practice
More informationMANITOBA RENAL PROGRAM
SUBJECT Venipuncture of Arteriovenous Fistula/Graft MANITOBA RENAL PROGRAM SECTION CODE 30.20.01 30.20 Vascular Access AUTHORIZATION Professional Advisory Committee, Manitoba Renal Program Nursing Practice
More informationWHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington
WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have
More informationThe Relationship Between Systemic and Whole-Body Hematocrit Is Not Constant during Ultrafiltration on Hemodialysis
J Am Soc Nephrol 15: 463 469, 2004 The Relationship Between Systemic and Whole-Body Hematocrit Is Not Constant during Ultrafiltration on Hemodialysis SANDIP MITRA,* PAUL CHAMNEY, ROGER GREENWOOD, and KEN
More informationPhysiology of Blood Purification: Dialysis & Apheresis. Outline. Solute Removal Mechanisms in RRT
Physiology of Blood Purification: Dialysis & Apheresis Jordan M. Symons, MD University of Washington School of Medicine Seattle Children s Hospital Outline Physical principles of mass transfer Hemodialysis
More informationPharmacokinetics I. Dr. M.Mothilal Assistant professor
Pharmacokinetics I Dr. M.Mothilal Assistant professor DRUG TRANSPORT For a drug to produce a therapeutic effect, it must reach to its target and it must accumulate at that site to reach to the minimum
More informationSystem Dynamics Highlights the Effect of Maintenance on Hemodialysis Performance
System Dynamics Highlights the Effect of Maintenance on Hemodialysis Performance Ahmad Taher Azar 1 Assistant Instructor, Systems and Biomedical Engineering Department Higher Technological Institute, Tenth
More informationSodium removal during pre-dilution haemofiltration
Nephrol Dial Transplant (2003) 18 [Suppl 7]: vii31 vii36 DOI: 10.1093/ndt/gfg1076 Sodium removal during pre-dilution haemofiltration Salvatore Di Filippo, Celestina Manzoni, Simeone Andrulli, Francesca
More informationMEDICAL EQUIPMENT II HEMODIALYSIS
MEDICAL EQUIPMENT II - 2012 HEMODIALYSIS Lecture 1 Prof. Yasser Mostafa Kadah Hemodialysis Machines Single-patient hemodialysis machines deliver a patient s dialysis prescription by controlling blood and
More informationC OBJECTIVES. Basic Pharmacokinetics LESSON. After completing Lesson 2, you should be able to:
LESSON 2 Basic Pharmacokinetics C OBJECTIVES After completing Lesson 2, you should be able to: 1. Define the concept of apparent volume of distribution and use an appropriate mathematical equation to calculate
More informationManaging Acid Base and Electrolyte Disturbances with RRT
Managing Acid Base and Electrolyte Disturbances with RRT John R Prowle MA MSc MD MRCP FFICM Consultant in Intensive Care & Renal Medicine RRT for Regulation of Acid-base and Electrolyte Acid base load
More informationOn-site production of a dialysis bath from dry salts. Results of solute concentration control by routine clinical chemistry
Clin Kidney J (2012) 5: 207 211 doi: 10.1093/ckj/sfs043 Original Article On-site production of a dialysis bath from dry salts. Results of solute concentration control by routine clinical chemistry Joachim
More informationABSOLUTE BLOOD FLOW MEASUREMENTS: PRINCIPLES
CORONARY PHYSIOLOGY IN THE CATHLAB: ABSOLUTE BLOOD FLOW MEASUREMENTS: PRINCIPLES Educational Training Program ESC European Heart House april 23rd - 25th 2015 Nico H. J. Pijls, MD, PhD Catharina Hospital,
More informationCan We Achieve Precision Solute Control with CRRT?
Can We Achieve Precision Solute Control with CRRT? Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference February, 2019 Disclosures I have no actual or potential
More informationGlossary of ESRD Terms
Glossary of ESRD Terms ACCESS: A means to reach the bloodstream, In hemodialysis, fistulas, grafts, catheters, and vascular accesses are used. Access to the peritoneal cavity for peritoneal dialysis is
More informationFundamentals of DIALYSIS
Fundamentals of DIALYSIS Knowing Your Kidneys Healthy Kidneys are the body s cleaning crew These are twin bean shaped organs, of the size of fist They make up a filter system for the blood & reabsorb almost
More informationSichol sooksee,rn. Hemodialysis Unit Rajavej Chiang Mai Hospital
Sichol sooksee,rn. Hemodialysis Unit Rajavej Chiang Mai Hospital Button hole or Ladder?? Vascular Access Cannulation It s a Life Line of Hemodialysis patient Arterio-venous fistula(avf) is the K/DOQI
More informationEnd-Stage Renal Disease. Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology
End-Stage Renal Disease Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology ESRD : Life with renal replacement therapy CASE: 18 month old male with HUS develops ESRD PD complicated
More informationKt/V underestimates the hemodialysis dose in women and small men
original article http://www.kidney-international.org & 8 International Society of Nephrology see commentary on page 262 Kt/V underestimates the hemodialysis dose in women and small men Elaine M. Spalding
More informationOne-Compartment Open Model: Intravenous Bolus Administration:
One-Compartment Open Model: Intravenous Bolus Administration: Introduction The most common and most desirable route of drug administration is orally by mouth using tablets, capsules, or oral solutions.
More informationECMO & Renal Failure Epidemeology Renal failure & effect on out come
ECMO Induced Renal Issues Transient renal dysfunction Improvement in renal function ECMO & Renal Failure Epidemeology Renal failure & effect on out come With or Without RRT Renal replacement Therapy Utilizes
More informationLow Blood Pressure During Dialysis (Intradialytic Hypotension (IDH))
Low Blood Pressure During Dialysis (Intradialytic Hypotension (IDH)) By Dori Schatell, Medical Education Institute One of the main jobs of dialysis is to remove excess water from your body. Seems pretty
More informationModes of Extracorporeal Therapies For ESRD Patients
Modes of Extracorporeal Therapies For ESRD Patients Suhail, MD Extracorporeal Therapies: Dialytic Therapies Dialysis: Movement of molecules across a semipermeable membrane (Bi-directional) Movement of
More informationDialysis Dose Prescription and Delivery. William Clark, M.D. Claudio Ronco, M.D. Rolando Claure-Del Granado, M.D. CRRT Conference February 15, 2012
Dialysis Dose Prescription and Delivery William Clark, M.D. Claudio Ronco, M.D. Rolando Claure-Del Granado, M.D. CRRT Conference February 15, 2012 Dose in RRT: Key concepts Dose definition Quantifying
More informationMeasurement of dialyzer clearance, dialysis time, and body size: Death risk relationships among patients
Kidney International, Vol. 66 (24), pp. 277 284 Measurement of dialyzer clearance, dialysis time, and body size: Death risk relationships among patients EDMUND G. LOWRIE,ZHENSHENG LI,NORMA OFSTHUN, and
More informationFrequently asked questions and answers:
Frequently asked questions and answers: General 1) What are the indications and contraindications for PiCCO-Technology? Indications: Patients in whom cardiovascular and circulatory volume status monitoring
More informationLesson #7: Quality Assessment and Performance Improvement
ESRD Update: Transitioning to New ESRD Conditions for Coverage Student Manual Lesson #7: Quality Assessment and Performance Improvement Learning Objectives At the conclusion of this lesson, you will be
More informationHemodialysis Adequacy: A Complex and Evolving Paradigm. Balazs Szamosfalvi, MD Monday, 08/30/ :00-09:45
Hemodialysis Adequacy: A Complex and Evolving Paradigm Balazs Szamosfalvi, MD Monday, 08/30/2010 09:00-09:45 Adequacy 1943-1970 Fresenius The patient survived the dialysis session Uremia improved Volume
More informationHemodialysis is a life-sustaining procedure for the treatment of
The Dialysis Prescription and Urea Modeling Biff F. Palmer Hemodialysis is a life-sustaining procedure for the treatment of patients with end-stage renal disease. In acute renal failure the procedure provides
More informationAssessment, Monitoring, and. Svetlana (Lana) Kacherova, ESRD Network 18, QI Director WebEx session, December 18, 2008
Vascular Access Assessment, Monitoring, and Surveillance Svetlana (Lana) Kacherova, ESRD Network 18, QI Director WebEx session, December 18, 2008 1 Special Acknowledgement for Content Contributions: RMS
More informationegfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31
Update on Renal Therapeutics Caroline Ashley Lead Pharmacist Renal Services UCL Centre for Nephrology, Royal Free Hospital, London Kongress für Arzneimittelinformation January 2011 What are we going to
More informationNephrology Dialysis Transplantation
Nephrol Dial Transplant (1998) 13: 745 749 Technical Note Nephrology Dialysis Transplantation Adequacy of haemodialysis with cuffed central-vein catheters Kraikerk Atherikul, Steve J. Schwab and Peter
More informationDiacap. Constant performance resulting in high quality dialysis. Avitum
Diacap Constant performance resulting in high quality dialysis Avitum B. Braun Avitum. Always with Passion. B. Braun is a leading international company in the healthcare market. With a long tradition stretching
More information